Cargando…

Role of MALDI-MSI in combination with 3D tissue models for early stage efficacy and safety testing of drugs and toxicants

Introduction: Three-dimensional (3D) cell cultures have become increasingly important materials to investigate biological processes and drug efficacy and toxicity. The ability of 3D cultures to mimic the physiology of primary tissues and organs in the human body enables further insight into cellular...

Descripción completa

Detalles Bibliográficos
Autores principales: Spencer, Chloe E, Flint, Lucy E, Duckett, Catherine J, Cole, Laura M, Cross, Neil, Smith, David P, Clench, Malcolm R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8396712/
https://www.ncbi.nlm.nih.gov/pubmed/33440126
http://dx.doi.org/10.1080/14789450.2021.1876568
_version_ 1783744436860092416
author Spencer, Chloe E
Flint, Lucy E
Duckett, Catherine J
Cole, Laura M
Cross, Neil
Smith, David P
Clench, Malcolm R
author_facet Spencer, Chloe E
Flint, Lucy E
Duckett, Catherine J
Cole, Laura M
Cross, Neil
Smith, David P
Clench, Malcolm R
author_sort Spencer, Chloe E
collection PubMed
description Introduction: Three-dimensional (3D) cell cultures have become increasingly important materials to investigate biological processes and drug efficacy and toxicity. The ability of 3D cultures to mimic the physiology of primary tissues and organs in the human body enables further insight into cellular behavior and is hence highly desirable in early-stage drug development. Analyzing the spatial distribution of drug compounds and endogenous molecules provides an insight into the efficacy of a drug whilst simultaneously giving information on biological responses. Areas Covered: In this review we will examine the main 3D cell culture systems employed and applications, which describe their integration with mass spectrometry imaging (MSI). Expert Opinion: MSI is a powerful technique that can map a vast range of molecules simultaneously in tissues without the addition of labels that can provide insights into the efficacy and safety of a new drug. The combination of MSI and 3D cell cultures has emerged as a promising tool in early-stage drug analysis. However, the most common administration route for pharmaceutical drugs is via oral delivery. The use of MSI in combination with models of the GI tract is an area that has been little explored to date, the reasons for this are discussed.
format Online
Article
Text
id pubmed-8396712
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Taylor & Francis
record_format MEDLINE/PubMed
spelling pubmed-83967122021-08-28 Role of MALDI-MSI in combination with 3D tissue models for early stage efficacy and safety testing of drugs and toxicants Spencer, Chloe E Flint, Lucy E Duckett, Catherine J Cole, Laura M Cross, Neil Smith, David P Clench, Malcolm R Expert Rev Proteomics Review Introduction: Three-dimensional (3D) cell cultures have become increasingly important materials to investigate biological processes and drug efficacy and toxicity. The ability of 3D cultures to mimic the physiology of primary tissues and organs in the human body enables further insight into cellular behavior and is hence highly desirable in early-stage drug development. Analyzing the spatial distribution of drug compounds and endogenous molecules provides an insight into the efficacy of a drug whilst simultaneously giving information on biological responses. Areas Covered: In this review we will examine the main 3D cell culture systems employed and applications, which describe their integration with mass spectrometry imaging (MSI). Expert Opinion: MSI is a powerful technique that can map a vast range of molecules simultaneously in tissues without the addition of labels that can provide insights into the efficacy and safety of a new drug. The combination of MSI and 3D cell cultures has emerged as a promising tool in early-stage drug analysis. However, the most common administration route for pharmaceutical drugs is via oral delivery. The use of MSI in combination with models of the GI tract is an area that has been little explored to date, the reasons for this are discussed. Taylor & Francis 2021-02-02 /pmc/articles/PMC8396712/ /pubmed/33440126 http://dx.doi.org/10.1080/14789450.2021.1876568 Text en © 2021 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review
Spencer, Chloe E
Flint, Lucy E
Duckett, Catherine J
Cole, Laura M
Cross, Neil
Smith, David P
Clench, Malcolm R
Role of MALDI-MSI in combination with 3D tissue models for early stage efficacy and safety testing of drugs and toxicants
title Role of MALDI-MSI in combination with 3D tissue models for early stage efficacy and safety testing of drugs and toxicants
title_full Role of MALDI-MSI in combination with 3D tissue models for early stage efficacy and safety testing of drugs and toxicants
title_fullStr Role of MALDI-MSI in combination with 3D tissue models for early stage efficacy and safety testing of drugs and toxicants
title_full_unstemmed Role of MALDI-MSI in combination with 3D tissue models for early stage efficacy and safety testing of drugs and toxicants
title_short Role of MALDI-MSI in combination with 3D tissue models for early stage efficacy and safety testing of drugs and toxicants
title_sort role of maldi-msi in combination with 3d tissue models for early stage efficacy and safety testing of drugs and toxicants
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8396712/
https://www.ncbi.nlm.nih.gov/pubmed/33440126
http://dx.doi.org/10.1080/14789450.2021.1876568
work_keys_str_mv AT spencerchloee roleofmaldimsiincombinationwith3dtissuemodelsforearlystageefficacyandsafetytestingofdrugsandtoxicants
AT flintlucye roleofmaldimsiincombinationwith3dtissuemodelsforearlystageefficacyandsafetytestingofdrugsandtoxicants
AT duckettcatherinej roleofmaldimsiincombinationwith3dtissuemodelsforearlystageefficacyandsafetytestingofdrugsandtoxicants
AT colelauram roleofmaldimsiincombinationwith3dtissuemodelsforearlystageefficacyandsafetytestingofdrugsandtoxicants
AT crossneil roleofmaldimsiincombinationwith3dtissuemodelsforearlystageefficacyandsafetytestingofdrugsandtoxicants
AT smithdavidp roleofmaldimsiincombinationwith3dtissuemodelsforearlystageefficacyandsafetytestingofdrugsandtoxicants
AT clenchmalcolmr roleofmaldimsiincombinationwith3dtissuemodelsforearlystageefficacyandsafetytestingofdrugsandtoxicants